How Yale, the FDA, and Merck Lied About Molnupiravir’s Inferiority to Ivermectin

Executive Summary

  • The health authorities have done their best to stigmatize the use of Ivermectin and promote far less effective and more risky drugs.
  • One of these is Molnupiravir.


Ivermectin is a drug that is highly effective against multiple ailments. However, Merck and the health authorities have decided to create fear around the medicine because this drug is now generic. While Merck was telling the public that therapeutics like Ivermectin were ineffective against covid, it was busy creating an on-patent substitute. This drug is called Molnupiravir. Ivermectin works for many ailments and is highly supportive of general health. This article will cover how pharmaceutical companies, health authorities, and establishment media they control push the public away from proven generic drugs to far more risky and less effective on-patent drugs.

Wait One Second...

Why is The Article Not Viewable?

You are seeing this text instead of the article because of two potential reasons.

Reason #1: You are a Subscriber but Not Signed In

The only reason this should happen is if you are using a different device than the one you signed up with. You can sign in by simply sending yourself a link to the email you signed in with by selecting the link below.

Sign In

You can read any article on the site as soon as you sign in.

Reason #2: You Are Not Yet Subscribed to the Site

This is a subscription site. That is how we pay for the research we do. We have to charge subscribers to access articles because, unlike WebMD, Healthline, or the Mayo Clinic, we don't allow pharmaceutical companies to write or edit our articles. 

You can access this and many other articles by becoming a subscriber.

How Do You Subscribe?

See the following article, which explains what you get with a subscription.


You can be reading this article and many others like it in just a few minutes from now.